학술논문

ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance
Document Type
article
Source
Cell. 184(20)
Subject
Genetics
Cancer
Breast Cancer
Human Genome
Generic health relevance
Animals
Base Sequence
Breast Neoplasms
Cell Line
Tumor
Cell Survival
Disease Progression
Drug Resistance
Neoplasm
Estrogen Receptor alpha
Eukaryotic Initiation Factor-4G
Female
Gene Expression Regulation
Neoplastic
Genomics
Humans
Mice
Inbred NOD
Myeloid Cell Leukemia Sequence 1 Protein
Oncogenes
Protein Binding
Protein Domains
RNA Splicing
RNA
Messenger
RNA-Binding Proteins
Stress
Physiological
Tamoxifen
X-Box Binding Protein 1
ERα
RNA splicing
RNA-binding protein
breast cancer
cell survival
integrated stress response
translation control
Biological Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
Estrogen receptor α (ERα) is a hormone receptor and key driver for over 70% of breast cancers that has been studied for decades as a transcription factor. Unexpectedly, we discover that ERα is a potent non-canonical RNA-binding protein. We show that ERα RNA binding function is uncoupled from its activity to bind DNA and critical for breast cancer progression. Employing genome-wide cross-linking immunoprecipitation (CLIP) sequencing and a functional CRISPRi screen, we find that ERα-associated mRNAs sustain cancer cell fitness and elicit cellular responses to stress. Mechanistically, ERα controls different steps of RNA metabolism. In particular, we demonstrate that ERα RNA binding mediates alternative splicing of XBP1 and translation of the eIF4G2 and MCL1 mRNAs, which facilitates survival upon stress conditions and sustains tamoxifen resistance of cancer cells. ERα is therefore a multifaceted RNA-binding protein, and this activity transforms our knowledge of post-transcriptional regulation underlying cancer development and drug response.